- "Adaptive design trial protocol" + "master statistical analysis plan" = statistical magic
- They say they measured hospitalization, but also counted "proxy hospitalization" in "mobile hospital-like services"
- They gave ivermectin only for 3 days (way too short)
- They started with 679 people in the treatment group and in the placebo group. Preconditions and chronic diseases were unevenly distributed between these groups => the trial was too small for useful results
- 21 vs. 24 deaths - deaths don't count in this study
(post is archived)